35 resultados.
With the vaccination of the first 25 volunteers in the 12-18 age group, Phase I clinical trials of the Soberana 02 candidate anti-COVID vaccine developed by the Finlay Vaccine Institute began yesterday, June 14
Army General Raúl Castro Ruz and President Miguel Díaz-Canel Bermúdez honored José Martí yesterday with some twenty young people who descended the steps of the University of Havana in the traditional March of the Torches.
A Phase I clinical trial based on the treatment of lung injury with autologous stem cells (derived from the patient's own blood) in COVID-19 patients with lung injury demonstrated the safety and efficacy of this therapy in the indication studied
The help of only five Cuban health care professionals was no small thing for the British island of Anguilla, where they contributed to the battle against COVID-19
Soberana 02 and Soberana Plus proved very effective in children aged two to 11 years during the wave of the Omicron variant.
